Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

Inclusion Criteria: * Women with confirmed pregnancy and registered to the antenatal care programme in the local health centre * Resident for at least 1 year in the study site * Age ≥ 15 * Accepting to participate with willingness to give informed consent (pregnant adolescents younger than 18 y/o (age \< 18) will be considered only if they are accompanied by parent or carer if it is requested by local Institutional Review Boards) * Willingness to provide finger-prick blood sample at enrolment Exclusion Criteria: * Past history of malaria and/or antimalarial drugs in the last three months * Positive for malaria by microscopy and conventional RDT testing in any previous study screening visit * Presence of severe malaria as defined by WHO guidelines at the moment of recruitment * Presence of symptoms and signs of other severe disease and central nervous system infections, as defined by WHO guidelines.